Associations of CYP2A6 genotype with smoking behaviors in southern China

被引:43
作者
Liu, Tao [1 ]
David, Sean P. [2 ,3 ,4 ,5 ,6 ]
Tyndale, Rachel F. [7 ,8 ,9 ]
Wang, Hui [1 ]
Zhou, Qian [7 ,8 ,9 ]
Ding, Peng [1 ]
He, Yan-Hui [1 ]
Yu, Xue-Qing [10 ]
Chen, Wei [10 ]
Crump, Casey [2 ,3 ]
Wen, Xiao-Zhong [11 ]
Chen, Wei-Qing [1 ]
机构
[1] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510080, Guangdong, Peoples R China
[2] Stanford Univ, Ctr Educ Family & Community Med, Stanford, CA 94305 USA
[3] Stanford Univ, Div Family & Community Med, Stanford, CA 94305 USA
[4] SRI Int, Menlo Pk, CA 94025 USA
[5] Brown Alpert Med Sch, Ctr Primary Care & Prevent, Pawtucket, RI USA
[6] Brown Alpert Med Sch, Dept Family Med, Pawtucket, RI USA
[7] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[8] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[9] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada
[10] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510275, Guangdong, Peoples R China
[11] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA
基金
美国国家卫生研究院;
关键词
Chinese smokers; CYP2A6; genetic polymorphisms; nicotine dependence; smoking cessation; smoking duration; smoking initiation; smoking quantity; SINGLE NUCLEOTIDE POLYMORPHISM; CYTOCHROME-P450; 2A6; CYP2A6; NATIONAL PREVALENCE SURVEY; NICOTINE METABOLITE RATIO; EMERGING TOBACCO HAZARDS; IN-VIVO; TRANSDERMAL NICOTINE; (+)-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE; GENETIC POLYMORPHISMS; ENZYMATIC-ACTIVITY;
D O I
10.1111/j.1360-0443.2010.03353.x
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To investigate the association of CYP2A6 genetic polymorphisms with smoking-related phenotypes in Chinese smokers. Design Case-only genetic association study. Setting Southern China. Participants A total of 1328 Han Chinese smokers who participated in a community-based chronic disease screening project in Guangzhou and Zhuhai from 2006 to 2007. Measurements All participants answered a structured questionnaire about socio-demographic status and smoking behaviors and informative alleles were genotyped for the cytochrome P450 2A6 (CYP2A6) gene (CYP2A6 *4, *5, *7, *9 and *10). Findings The frequencies of CYP2A6 *4, *5, *7, *9 and *10 alleles were 8.5, 1.2, 6.3, 13.5 and 2.4%, which corresponded to 48.9, 15.4, 24.2 and 11.5% of participants being classified as normal, intermediate, slow and poor metabolizers, respectively. Multivariate analyses in male smokers demonstrated that compared with normal metabolizers, poor metabolizers reported smoking fewer cigarettes per day [adjusted odds ratio (OR) = 0.49; 95% confidence interval (CI): 0.32-0.76], started smoking regularly later in life (adjusted OR = 1.55; 95% CI: 1.06-2.26) and, among former smokers, reported smoking for a shorter duration prior to quitting (adjusted OR = 0.33; 95% CI: 0.12-0.94). However, poor metabolizers were less likely to quit smoking and remain abstinent than normal metabolizers (adjusted OR = 0.54; 95% CI: 0.34-0.86). Conclusions Reduced metabolism function of cytochrome P450 2A6 in smokers appears to be associated with fewer cigarettes smoked, later initiation of smoking regularly, shorter smoking duration and lower likelihood of smoking cessation.
引用
收藏
页码:985 / 994
页数:10
相关论文
共 50 条
  • [21] CYP2A6 gene variants may explain smoking status in a Turkish cohort
    Pehlivan, Sacide
    Uysal, Mehmet Atilla
    Cagatay, Tulin
    Nursal, Ayse Feyda
    Cinar, Cigdem Kekik
    Erkan, Feyza
    Sever, Ulgen
    Bingol, Zuleyha
    Pehlivan, Mustafa
    Pence, Sadrettin
    PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY, 2019, 29 (03) : 340 - 345
  • [22] Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior
    Thorgeirsson, Thorgeir E.
    Gudbjartsson, Daniel F.
    Surakka, Ida
    Vink, Jacqueline M.
    Amin, Najaf
    Geller, Frank
    Sulem, Patrick
    Rafnar, Thorunn
    Esko, Tonu
    Walter, Stefan
    Gieger, Christian
    Rawal, Rajesh
    Mangino, Massimo
    Prokopenko, Inga
    Magi, Reedik
    Keskitalo, Kaisu
    Gudjonsdottir, Iris H.
    Gretarsdottir, Solveig
    Stefansson, Hreinn
    Thompson, John R.
    Aulchenko, Yurii S.
    Nelis, Mari
    Aben, Katja K.
    den Heijer, Martin
    Dirksen, Asger
    Ashraf, Haseem
    Soranzo, Nicole
    Valdes, Ana M.
    Steves, Claire
    Uitterlinden, Andre G.
    Hofman, Albert
    Tonjes, Anke
    Kovacs, Peter
    Hottenga, Jouke Jan
    Willemsen, Gonneke
    Vogelzangs, Nicole
    Doering, Angela
    Dahmen, Norbert
    Nitz, Barbara
    Pergadia, Michele L.
    Saez, Berta
    De Diego, Veronica
    Lezcano, Victoria
    Garcia-Prats, Maria D.
    Ripatti, Samuli
    Perola, Markus
    Kettunen, Johannes
    Hartikainen, Anna-Liisa
    Pouta, Anneli
    Laitinen, Jaana
    NATURE GENETICS, 2010, 42 (05) : 448 - U135
  • [23] CYP2A6 Genotype but not Age Determines Cotinine Half-Life in Infants and Children
    Dempsey, D. A.
    Sambol, N. C.
    Jacob, P., III
    Hoffmann, E.
    Tyndale, R. F.
    Fuentes-Afflick, E.
    Benowitz, N. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (03) : 400 - 406
  • [24] CYP2A6 genotyping methods and strategies using real-time and end point PCR platforms
    Wassenaar, Catherine A.
    Zhou, Qian
    Tyndale, Rachel F.
    PHARMACOGENOMICS, 2016, 17 (02) : 147 - 162
  • [25] Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity
    El-Boraie, Ahmed
    Taghavi, Taraneh
    Chenoweth, Meghan J.
    Fukunaga, Koya
    Mushiroda, Taisei
    Kubo, Michiaki
    Lerman, Caryn
    Nollen, Nicole L.
    Benowitz, Neal L.
    Tyndale, Rachel F.
    ADDICTION BIOLOGY, 2020, 25 (01)
  • [26] Relationship Between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 Variation and Smoking Behaviors and Lung Cancer Risk
    Wassenaar, Catherine A.
    Dong, Qiong
    Wei, Qingyi
    Amos, Christopher I.
    Spitz, Margaret R.
    Tyndale, Rachel F.
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (17) : 1342 - 1346
  • [27] Effect of genotype and methylation of CYP2D6 on smoking behaviour
    Tiili, Emmi M.
    Antikainen, Miia S. H.
    Mitiushkina, Natalia V.
    Sukhovskaya, Olga A.
    Imyanitov, Evgeny N.
    Hirvonen, Ari P.
    PHARMACOGENETICS AND GENOMICS, 2015, 25 (11) : 531 - 540
  • [28] Genetic polymorphisms and phenotypic analysis of CYP2A6 in the Sherpa population
    He, Xue
    Sun, Fang
    Zhang, Ning
    Zhu, Xikai
    Ma, Lifeng
    Zhang, Xiyang
    Zhang, Yuan
    Kang, Longli
    Jin, Tianbo
    Yuan, Dongya
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10474 - 10482
  • [29] Functional characterization of novel rare CYP2A6 variants and potential implications for clinical outcomes
    El-Boraie, Ahmed
    Tanner, Julie-Anne
    Zhu, Andy Z. X.
    Claw, Katrina G.
    Prasad, Bhagwat
    Schuetz, Erin G.
    Thummel, Kenneth E.
    Fukunaga, Koya
    Mushiroda, Taisei
    Kubo, Michiaki
    Benowitz, Neal L.
    Lerman, Caryn
    Tyndale, Rachel F.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (01): : 204 - 220
  • [30] Influence of CYP2A6 Genetic Variation, Nicotine Dependence Severity, and Treatment on Smoking Cessation Success
    Chenoweth, Meghan J.
    Lerman, Caryn
    Knight, Jo
    Tyndale, Rachel F.
    NICOTINE & TOBACCO RESEARCH, 2023, 25 (06) : 1207 - 1211